首页 > 最新文献

Clinical and Experimental Gastroenterology最新文献

英文 中文
Colorectal Endoscopic Submucosal Dissection: An Update on Best Practice. 结直肠内镜黏膜下剥离术:最佳实践的更新。
IF 2.5 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-08-03 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S249869
Tara Keihanian, Mohamed O Othman

Endoscopic submucosal dissection (ESD) is a method of en-bloc resection of neoplastic colorectal lesions which is less invasive compared to surgical resection. Lesion stratification, architecture recognition and estimation of depth of invasion are crucial for patient selection. Expert endoscopists have integrated a variety of classification systems including Paris, lateral spreading tumor (LST), narrow band imaging (NBI), international colorectal endoscopic (NICE) and Japanese NBI expert team (JNET) in their day-to-day practice to enhance lesion detection accuracy. Major societies recommend ESD for LST-non granular (NG), Kudo-VI type, large depressed and protruded colonic lesions with shallow submucosal invasion. Chance of submucosal invasion enhances with increased depth as well as tumor location and size. In comparison to endoscopic mucosal resection (EMR), ESD has a lowerl recurrence rate and higher curative resection rate, making it superior for larger colonic lesions management. Major complications such as bleeding and perforation could be seen in up to 11% and 16% of patients, respectively. In major Western countries, performing ESD is challenging due to limited number of expert providers, lack of insurance coverage, and unique patient characteristics such as higher BMI and higher percentage of previously manipulated lesions.

内镜下粘膜下剥离术(ESD)是一种对结肠直肠肿瘤病变进行全切的方法,与手术切除相比创伤更小。病变分层、结构识别和侵袭深度评估对患者的选择至关重要。内镜专家在日常实践中整合了多种分类系统,包括巴黎系统、侧蔓延肿瘤(LST)、窄带成像(NBI)、国际结直肠内镜(NICE)和日本 NBI 专家小组(JNET),以提高病变检测的准确性。主要学会建议对 LST-非颗粒(NG)、Kudo-VI 型、大的凹陷和突出结肠病变且粘膜下侵犯较浅的患者进行 ESD。随着肿瘤深度、位置和大小的增加,粘膜下侵犯的几率也会增加。与内镜粘膜切除术(EMR)相比,ESD 的复发率较低,治愈切除率较高,因此在处理较大的结肠病变时更具优势。出血和穿孔等主要并发症的发生率分别高达 11% 和 16%。在主要西方国家,由于专家提供者数量有限、缺乏保险以及患者的特殊性(如较高的体重指数和较高的既往病变比例),ESD 的实施具有挑战性。
{"title":"Colorectal Endoscopic Submucosal Dissection: An Update on Best Practice.","authors":"Tara Keihanian, Mohamed O Othman","doi":"10.2147/CEG.S249869","DOIUrl":"10.2147/CEG.S249869","url":null,"abstract":"<p><p>Endoscopic submucosal dissection (ESD) is a method of en-bloc resection of neoplastic colorectal lesions which is less invasive compared to surgical resection. Lesion stratification, architecture recognition and estimation of depth of invasion are crucial for patient selection. Expert endoscopists have integrated a variety of classification systems including Paris, lateral spreading tumor (LST), narrow band imaging (NBI), international colorectal endoscopic (NICE) and Japanese NBI expert team (JNET) in their day-to-day practice to enhance lesion detection accuracy. Major societies recommend ESD for LST-non granular (NG), Kudo-VI type, large depressed and protruded colonic lesions with shallow submucosal invasion. Chance of submucosal invasion enhances with increased depth as well as tumor location and size. In comparison to endoscopic mucosal resection (EMR), ESD has a lowerl recurrence rate and higher curative resection rate, making it superior for larger colonic lesions management. Major complications such as bleeding and perforation could be seen in up to 11% and 16% of patients, respectively. In major Western countries, performing ESD is challenging due to limited number of expert providers, lack of insurance coverage, and unique patient characteristics such as higher BMI and higher percentage of previously manipulated lesions.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"317-330"},"PeriodicalIF":2.5,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/e4/ceg-14-317.PMC8349195.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39298582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Patients' Immunoglobulin E Levels and Difficulty Eradicating Helicobacter pylori. 患者免疫球蛋白E水平与幽门螺杆菌根除难度的关系
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-07-27 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S322512
Kayoko Ozeki, Takahisa Furuta, Toshiyuki Ojima

Background: Helicobacter pylori is a cause of gastric cancer, and thus the eradication of this bacterium is very important. The success rate of primary eradication has been dramatically increased by the introduction of potassium-competitive acid blockers. However, H. pylori cannot be eradicated in all patients, and the contributing factors need to be clarified.

Aim: Because allergy status may be a factor and considering research linking hay fever with eradication failure, the purpose of this study was to examine blood immunoglobulin E levels as a contributing factor in patients who were unable to eradicate H. pylori in a single eradication treatment and who underwent multiple eradication attempts.

Methods: Questionnaire data were collected from 250 patients who visited the Department of Gastroenterology, Hamamatsu University School of Medicine, for H. pylori eradication. In addition, non-specific IgE levels in the blood were measured and analyzed with one-way analysis of variance. Multinomial logistic regression analysis was performed to examine the association between the number of eradication attempts and the IgE level (< 500 vs ≥ 500 IU/mL).

Results: The mean IgE values were 188.4, 211.9, and 744.0 IU/mL in patients with one, two, and three or more eradication attempts, respectively (P < 0.05). The results of multinomial logistic regression analysis showed that attempting eradication three or more times was significantly associated with high levels of IgE, even after consideration of antibiotic sensitivity.

Conclusion: H. pylori eradication was less likely in patients with high IgE. It is thus necessary to study the appropriate regimen for patients with high IgE levels.

背景:幽门螺杆菌是胃癌的病因之一,因此根除这种细菌是非常重要的。通过引入钾竞争酸阻滞剂,原发性根除的成功率大大提高。然而,幽门螺旋杆菌不可能在所有患者中被根除,其致病因素需要明确。目的:由于过敏状态可能是一个因素,并且考虑到将花粉热与根除失败联系起来的研究,本研究的目的是检查血液免疫球蛋白E水平是否在单次根除治疗中无法根除幽门螺杆菌并进行多次根除尝试的患者中起作用。方法:对滨松大学医学院消化内科接受幽门螺杆菌根除治疗的250例患者进行问卷调查。此外,测量血液中非特异性IgE水平,并采用单因素方差分析进行分析。采用多项logistic回归分析检验根除次数与IgE水平(< 500 vs≥500 IU/mL)之间的关系。结果:1次、2次、3次及以上患者的平均IgE值分别为188.4、211.9、744.0 IU/mL (P < 0.05)。多项逻辑回归分析的结果显示,尝试根除三次或更多次与高水平的IgE显著相关,即使考虑到抗生素敏感性。结论:高IgE患者幽门螺杆菌根除的可能性较低。因此,有必要研究适合高IgE患者的治疗方案。
{"title":"Association Between Patients' Immunoglobulin E Levels and Difficulty Eradicating <i>Helicobacter pylori</i>.","authors":"Kayoko Ozeki,&nbsp;Takahisa Furuta,&nbsp;Toshiyuki Ojima","doi":"10.2147/CEG.S322512","DOIUrl":"https://doi.org/10.2147/CEG.S322512","url":null,"abstract":"<p><strong>Background: </strong><i>Helicobacter pylori</i> is a cause of gastric cancer, and thus the eradication of this bacterium is very important. The success rate of primary eradication has been dramatically increased by the introduction of potassium-competitive acid blockers. However, <i>H. pylori</i> cannot be eradicated in all patients, and the contributing factors need to be clarified.</p><p><strong>Aim: </strong>Because allergy status may be a factor and considering research linking hay fever with eradication failure, the purpose of this study was to examine blood immunoglobulin E levels as a contributing factor in patients who were unable to eradicate <i>H. pylori</i> in a single eradication treatment and who underwent multiple eradication attempts.</p><p><strong>Methods: </strong>Questionnaire data were collected from 250 patients who visited the Department of Gastroenterology, Hamamatsu University School of Medicine, for <i>H. pylori</i> eradication. In addition, non-specific IgE levels in the blood were measured and analyzed with one-way analysis of variance. Multinomial logistic regression analysis was performed to examine the association between the number of eradication attempts and the IgE level (< 500 vs ≥ 500 IU/mL).</p><p><strong>Results: </strong>The mean IgE values were 188.4, 211.9, and 744.0 IU/mL in patients with one, two, and three or more eradication attempts, respectively (P < 0.05). The results of multinomial logistic regression analysis showed that attempting eradication three or more times was significantly associated with high levels of IgE, even after consideration of antibiotic sensitivity.</p><p><strong>Conclusion: </strong><i>H. pylori</i> eradication was less likely in patients with high IgE. It is thus necessary to study the appropriate regimen for patients with high IgE levels.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"311-316"},"PeriodicalIF":2.4,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/50/94/ceg-14-311.PMC8325756.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39272769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erratum: Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions [Corrigendum]. 勘误:毒性巨结肠:背景,病理生理学,管理挑战和解决方案[勘误]。
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-07-19 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S329394

[This corrects the article DOI: 10.2147/CEG.S200760.].

[更正文章DOI: 10.2147/CEG.S200760.]。
{"title":"Erratum: Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions [Corrigendum].","authors":"","doi":"10.2147/CEG.S329394","DOIUrl":"https://doi.org/10.2147/CEG.S329394","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.2147/CEG.S200760.].</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"309-310"},"PeriodicalIF":2.4,"publicationDate":"2021-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/34/ceg-14-309.PMC8302810.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39254043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Ominous Ouzo Party - A Case Series of Four Patients with Accidental Alkali Ingestion. 不祥的乌佐党——四例意外误食碱患者的病例系列。
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-07-13 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S320047
Marcel Vetter, Timo Rath, Jürgen Siebler, Maximilian Waldner, Markus F Neurath, Lukas Pfeifer

Background: Ingestion of alkaline fluids is a common problem, which can lead to perforations, strictures and malignancy. We present a rare case series of several patients who accidentally ingested the same alkaline substance in different doses.

Methods: We investigated four patients with accidental ingestion of dishwashing liquid. All patients underwent gastroscopy within 24h after inpatient admission. Gastroesophageal lesions were classified according to the Zargar classification for corrosive ingestions.

Results: Esophagogastric lesions were predominantly found at the distal esophagus and the small curvature of the stomach. The severity of these lesions ranged from mild erosions (Zargar 2A) to marked necrosis (Zargar 3A). Our data suggest that the degree of these lesions correlated with the amount of ingested toxin and duration of the inpatient stay. However, a low symptom severity or inconspicuous otolaryngologic examination did not exclude severe gastroesophageal lesions.

Conclusion: Our data suggest that the severity of gastroesophageal lesions correlates with the amount of ingested alkaline substance. Symptom burden and an otolaryngologic examination are not sufficiently predictive for the severity of gastroesophageal lesions. The composition and quantity of the swallowed liquid should be determined.

背景:摄取碱性液体是一种常见的问题,可导致穿孔、狭窄和恶性肿瘤。我们提出一个罕见的病例系列的几个病人意外摄入相同的碱性物质在不同的剂量。方法:对4例误食洗碗液的患者进行调查。所有患者均在入院后24小时内行胃镜检查。胃食管病变按照腐蚀性食入的Zargar分类进行分类。结果:食管胃病变主要发生在食管远端和胃小弯曲处。这些病变的严重程度从轻度侵蚀(Zargar 2A)到明显坏死(Zargar 3A)不等。我们的数据表明,这些病变的程度与摄入毒素的量和住院时间有关。然而,症状严重程度低或耳鼻喉科检查不明显不能排除严重的胃食管病变。结论:我们的数据表明胃食管病变的严重程度与摄入碱性物质的量有关。症状负担和耳鼻喉科检查不足以预测胃食管病变的严重程度。应确定所吞液体的成分和量。
{"title":"The Ominous Ouzo Party - A Case Series of Four Patients with Accidental Alkali Ingestion.","authors":"Marcel Vetter,&nbsp;Timo Rath,&nbsp;Jürgen Siebler,&nbsp;Maximilian Waldner,&nbsp;Markus F Neurath,&nbsp;Lukas Pfeifer","doi":"10.2147/CEG.S320047","DOIUrl":"https://doi.org/10.2147/CEG.S320047","url":null,"abstract":"<p><strong>Background: </strong>Ingestion of alkaline fluids is a common problem, which can lead to perforations, strictures and malignancy. We present a rare case series of several patients who accidentally ingested the same alkaline substance in different doses.</p><p><strong>Methods: </strong>We investigated four patients with accidental ingestion of dishwashing liquid. All patients underwent gastroscopy within 24h after inpatient admission. Gastroesophageal lesions were classified according to the Zargar classification for corrosive ingestions.</p><p><strong>Results: </strong>Esophagogastric lesions were predominantly found at the distal esophagus and the small curvature of the stomach. The severity of these lesions ranged from mild erosions (Zargar 2A) to marked necrosis (Zargar 3A). Our data suggest that the degree of these lesions correlated with the amount of ingested toxin and duration of the inpatient stay. However, a low symptom severity or inconspicuous otolaryngologic examination did not exclude severe gastroesophageal lesions.</p><p><strong>Conclusion: </strong>Our data suggest that the severity of gastroesophageal lesions correlates with the amount of ingested alkaline substance. Symptom burden and an otolaryngologic examination are not sufficiently predictive for the severity of gastroesophageal lesions. The composition and quantity of the swallowed liquid should be determined.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"303-308"},"PeriodicalIF":2.4,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/95/ceg-14-303.PMC8286424.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39202780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatectomy with Takasaki's Technique Using SonaStar Ultrasonic Aspiration System: An Experience from 58 Cases. SonaStar超声抽吸系统Takasaki技术肝切除术58例体会。
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-22 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S319434
Van Linh Ho, Nhu Hien Pham, Thanh Xuan Nguyen, An Phong Tran, Nhu Thanh Dang, Nhu Hiep Pham

Objective: This study aims to explore the short-term results of hepatectomy with Takasaki's technique using Sonastar ultrasonic aspiration system.

Materials and methods: We retrospectively examined data of 58 patients who underwent hepatectomy with Takasaki's technique using Sonastar ultrasonic aspiration system at Hue Central Hospital from 01/2018 to 02/2021.

Results: The mean age was 60.7 ± 10.5 years (25-80) and the male/female ratio was 6:1. Patients with solitary tumor accounted for 79%; 68.4% had tumor size greater than 5 cm. Pringle maneuver was used in 57.9%, while selective right or left Glissonean pedicle occlusion was used in 69.0% and 32.8%, respectively. Final transection surface reinforcement was achieved by Surgicel and BioGlue in 78.9% and 21.5% of cases, respectively. Major liver resection accounted for 73.7%. The mean parenchymal transection time was 50 (45-110) minutes, while mean total operative time was 125 (90-280) minutes. Mean operative blood loss was 250 (150-650) mL. Mean post-operative hospital stay was 8 days (7-23). Post-operative complication rate was 15.9% and mortality rate was 1.7%.

Conclusion: Hepatectomy using Takasaki technique with Sonastar ultrasonic aspiration system is safe, effective, allowing an anatomical resection with sufficient safety margin and resulting in low complication rates (liver failure, biliary leakage) and good survival outcomes.

目的:探讨Sonastar超声抽吸系统在高崎肝切除术中的短期效果。材料和方法:我们回顾性分析了2018年1月至2021年2月在顺化中心医院使用Sonastar超声吸吸系统接受Takasaki技术肝切除术的58例患者的资料。结果:平均年龄60.7±10.5岁(25 ~ 80岁),男女比例为6:1。单发肿瘤患者占79%;肿瘤大小大于5 cm的占68.4%。Pringle手法占57.9%,选择性右或左Glissonean蒂闭塞分别占69.0%和32.8%。在78.9%和21.5%的病例中,Surgicel和biglue分别完成了最终的横断表面加固。大肝切除术占73.7%。平均横断时间为50(45-110)分钟,平均总手术时间为125(90-280)分钟。平均手术失血量250 (150 ~ 650)mL,平均术后住院时间8天(7 ~ 23)。术后并发症发生率为15.9%,死亡率为1.7%。结论:采用Takasaki技术联合Sonastar超声抽吸系统行肝切除术安全、有效,解剖切除有足够的安全余地,并发症发生率低(肝功能衰竭、胆漏),生存期好。
{"title":"Hepatectomy with Takasaki's Technique Using SonaStar Ultrasonic Aspiration System: An Experience from 58 Cases.","authors":"Van Linh Ho,&nbsp;Nhu Hien Pham,&nbsp;Thanh Xuan Nguyen,&nbsp;An Phong Tran,&nbsp;Nhu Thanh Dang,&nbsp;Nhu Hiep Pham","doi":"10.2147/CEG.S319434","DOIUrl":"https://doi.org/10.2147/CEG.S319434","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to explore the short-term results of hepatectomy with Takasaki's technique using Sonastar ultrasonic aspiration system.</p><p><strong>Materials and methods: </strong>We retrospectively examined data of 58 patients who underwent hepatectomy with Takasaki's technique using Sonastar ultrasonic aspiration system at Hue Central Hospital from 01/2018 to 02/2021.</p><p><strong>Results: </strong>The mean age was 60.7 ± 10.5 years (25-80) and the male/female ratio was 6:1. Patients with solitary tumor accounted for 79%; 68.4% had tumor size greater than 5 cm. Pringle maneuver was used in 57.9%, while selective right or left Glissonean pedicle occlusion was used in 69.0% and 32.8%, respectively. Final transection surface reinforcement was achieved by Surgicel and BioGlue in 78.9% and 21.5% of cases, respectively. Major liver resection accounted for 73.7%. The mean parenchymal transection time was 50 (45-110) minutes, while mean total operative time was 125 (90-280) minutes. Mean operative blood loss was 250 (150-650) mL. Mean post-operative hospital stay was 8 days (7-23). Post-operative complication rate was 15.9% and mortality rate was 1.7%.</p><p><strong>Conclusion: </strong>Hepatectomy using Takasaki technique with Sonastar ultrasonic aspiration system is safe, effective, allowing an anatomical resection with sufficient safety margin and resulting in low complication rates (liver failure, biliary leakage) and good survival outcomes.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"297-302"},"PeriodicalIF":2.4,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/d4/ceg-14-297.PMC8235924.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39040174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnostic Value of 14C Urea Breath Test for Helicobacter pylori Detection Compared by Histopathology in Indonesian Dyspeptic Patients. 与组织病理学相比,14C 尿素呼气试验对印尼消化不良患者幽门螺旋杆菌检测的诊断价值
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-14 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S306626
Muhammad Miftahussurur, Adinta Windia, Ari Fahrial Syam, Iswan Abbas Nusi, Ricky Indra Alfaray, Kartika Afrida Fauzia, Hartono Kahar, Herry Purbayu, Titong Sugihartono, Poernomo Boedi Setiawan, Ummi Maimunah, Ulfa Kholili, Husin Thamrin, Amie Vidyani, Dalla Doohan, Langgeng Agung Waskito, Yudith Annisa Ayu Rezkitha, Gontar Alamsyah Siregar, Yoshio Yamaoka

Purpose: Histopathology method is often used as a gold standard diagnostic for Helicobacter pylori infection in Indonesia. However, it requires an endoscopic procedure which is limited in Indonesia. A non-invasive method, such as 14C Urea Breath Test (UBT), is more favorable; however, this particular method has not been validated yet.

Patients and methods: A total of 55 dyspeptic patients underwent gastroscopy and 14C-UBT test. We used Heliprobe® UBT for UBT test. As for the histology, May-Giemsa staining of two gastric biopsies (from the antrum and corpus) were evaluated following the Updated Sydney System.

Results: The Receiver Operating Characteristics analysis showed that the optimum cut-off value was 57 with excellence Area under Curve = 0.955 (95% CI = 0.861-1.000). By applying the optimum cut-off value, Heliprobe® UBT showed 92.31% for sensitivity, 97.62% for specificity, 92.31% for positive predictive value, 97.62% for negative predictive value, 38.77 for positive likelihood ratio, 0.0788 for negative likelihood ratio, and 96.36% for the accuracy.

Conclusion: The 14C-UBT is an accurate test for H. pylori diagnosis with excellent sensitivity, specificity, and accuracy. The different optimum cut-off points suggested that a validation is absolutely necessary for new test prior application to the new population.

目的:在印度尼西亚,组织病理学方法通常被用作诊断幽门螺旋杆菌感染的金标准。然而,这种方法需要进行内窥镜检查,这在印尼是有限的。14C尿素呼气试验(UBT)等非侵入性方法更为有利,但这种特殊方法尚未得到验证:共有 55 名消化不良患者接受了胃镜检查和 14C-UBT 测试。我们使用 Heliprobe® UBT 进行 UBT 检测。在组织学方面,我们按照 "最新悉尼系统 "对两份胃活检组织(分别来自胃窦和胃体)进行了 May-Giemsa 染色评估:接收者工作特征分析显示,最佳临界值为 57,卓越曲线下面积 = 0.955 (95% CI = 0.861-1.000)。采用最佳临界值后,Heliprobe® UBT 的灵敏度为 92.31%,特异度为 97.62%,阳性预测值为 92.31%,阴性预测值为 97.62%,阳性似然比为 38.77,阴性似然比为 0.0788,准确率为 96.36%:14C-UPT是一种准确的幽门螺杆菌诊断检测方法,具有极佳的敏感性、特异性和准确性。不同的最佳临界点表明,新检测方法在应用于新人群之前绝对有必要进行验证。
{"title":"Diagnostic Value of <sup>14</sup>C Urea Breath Test for <i>Helicobacter pylori</i> Detection Compared by Histopathology in Indonesian Dyspeptic Patients.","authors":"Muhammad Miftahussurur, Adinta Windia, Ari Fahrial Syam, Iswan Abbas Nusi, Ricky Indra Alfaray, Kartika Afrida Fauzia, Hartono Kahar, Herry Purbayu, Titong Sugihartono, Poernomo Boedi Setiawan, Ummi Maimunah, Ulfa Kholili, Husin Thamrin, Amie Vidyani, Dalla Doohan, Langgeng Agung Waskito, Yudith Annisa Ayu Rezkitha, Gontar Alamsyah Siregar, Yoshio Yamaoka","doi":"10.2147/CEG.S306626","DOIUrl":"10.2147/CEG.S306626","url":null,"abstract":"<p><strong>Purpose: </strong>Histopathology method is often used as a gold standard diagnostic for <i>Helicobacter pylori</i> infection in Indonesia. However, it requires an endoscopic procedure which is limited in Indonesia. A non-invasive method, such as <sup>14</sup>C Urea Breath Test (UBT), is more favorable; however, this particular method has not been validated yet.</p><p><strong>Patients and methods: </strong>A total of 55 dyspeptic patients underwent gastroscopy and <sup>14</sup>C-UBT test. We used Heliprobe<sup>®</sup> UBT for UBT test. As for the histology, May-Giemsa staining of two gastric biopsies (from the antrum and corpus) were evaluated following the Updated Sydney System.</p><p><strong>Results: </strong>The Receiver Operating Characteristics analysis showed that the optimum cut-off value was 57 with excellence Area under Curve = 0.955 (95% CI = 0.861-1.000). By applying the optimum cut-off value, Heliprobe<sup>®</sup> UBT showed 92.31% for sensitivity, 97.62% for specificity, 92.31% for positive predictive value, 97.62% for negative predictive value, 38.77 for positive likelihood ratio, 0.0788 for negative likelihood ratio, and 96.36% for the accuracy.</p><p><strong>Conclusion: </strong>The <sup>14</sup>C-UBT is an accurate test for <i>H. pylori</i> diagnosis with excellent sensitivity, specificity, and accuracy. The different optimum cut-off points suggested that a validation is absolutely necessary for new test prior application to the new population.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"291-296"},"PeriodicalIF":2.4,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/69/ceg-14-291.PMC8213946.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39099086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Antibiotic-Refractory Pouchitis: Management Challenges. 慢性抗生素难治性袋炎:管理挑战。
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-14 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S219556
An Outtier, Marc Ferrante

Background: Pouchitis is the most common long-term complication in patients with ulcerative colitis who underwent restorative proctocolectomy with ileal pouch-anal anastomosis. The incidence of acute pouchitis is 20% after 1 year and up to 40% after 5 years. Chronic antibiotic-refractory pouchitis develops in approximately 10% of patients.

Aim: To present a narrative review of published literature regarding the management of chronic antibiotic-refractory pouchitis.

Methods: Current relevant literature was summarized and critically evaluated.

Results: Clear definitions should be used to classify pouchitis into acute versus chronic, and responsive versus dependent versus refractory to antibiotics. Before treatment is started for chronic antibiotic-refractory pouchitis, secondary causes should be ruled out. There is a need for validated scoring systems to measure the severity of the disease. Because chronic antibiotic-refractory pouchitis is a rare condition, only small studies with often a poor study design have been performed. Treatments with antibiotics, aminosalicylates, steroids, immunomodulators and biologics have shown to be effective and safe for chronic antibiotic-refractory pouchitis. Also, treatments with AST-120, hyperbaric oxygen therapy, tacrolimus enemas, and granulocyte and monocyte apheresis suggested some efficacy.

Conclusion: The available data are weak but suggest that therapeutic options for chronic antibiotic-refractory pouchitis are similar to the treatment strategies for inflammatory bowel diseases. However, randomized controlled trials are warranted to further identify the best treatment options in this patient population.

背景:袋炎是溃疡性结肠炎患者行恢复性直结肠切除术回肠袋肛吻合术最常见的长期并发症。1年后急性袋炎的发生率为20%,5年后高达40%。慢性抗生素难治性眼袋炎发生在大约10%的患者中。目的:对已发表的关于慢性抗生素难治性眼袋炎治疗的文献进行综述。方法:对现有相关文献进行总结和批判性评价。结果:应使用明确的定义将袋炎分为急性与慢性,对抗生素反应性、依赖性和难治性。在开始治疗慢性抗生素难治性眼袋炎之前,应排除继发性原因。有必要建立有效的评分系统来衡量疾病的严重程度。由于慢性抗生素难治性眼袋炎是一种罕见的疾病,因此只进行了小型研究,而且研究设计往往很差。抗生素、氨基水杨酸盐、类固醇、免疫调节剂和生物制剂治疗慢性抗生素难治性眼袋炎是有效和安全的。此外,AST-120治疗、高压氧治疗、他克莫司灌肠、粒细胞和单核细胞分离也显示出一定的疗效。结论:现有的数据很薄弱,但表明慢性抗生素难治性眼袋炎的治疗方案与炎症性肠病的治疗策略相似。然而,需要随机对照试验来进一步确定该患者群体的最佳治疗方案。
{"title":"Chronic Antibiotic-Refractory Pouchitis: Management Challenges.","authors":"An Outtier,&nbsp;Marc Ferrante","doi":"10.2147/CEG.S219556","DOIUrl":"https://doi.org/10.2147/CEG.S219556","url":null,"abstract":"<p><strong>Background: </strong>Pouchitis is the most common long-term complication in patients with ulcerative colitis who underwent restorative proctocolectomy with ileal pouch-anal anastomosis. The incidence of acute pouchitis is 20% after 1 year and up to 40% after 5 years. Chronic antibiotic-refractory pouchitis develops in approximately 10% of patients.</p><p><strong>Aim: </strong>To present a narrative review of published literature regarding the management of chronic antibiotic-refractory pouchitis.</p><p><strong>Methods: </strong>Current relevant literature was summarized and critically evaluated.</p><p><strong>Results: </strong>Clear definitions should be used to classify pouchitis into acute versus chronic, and responsive versus dependent versus refractory to antibiotics. Before treatment is started for chronic antibiotic-refractory pouchitis, secondary causes should be ruled out. There is a need for validated scoring systems to measure the severity of the disease. Because chronic antibiotic-refractory pouchitis is a rare condition, only small studies with often a poor study design have been performed. Treatments with antibiotics, aminosalicylates, steroids, immunomodulators and biologics have shown to be effective and safe for chronic antibiotic-refractory pouchitis. Also, treatments with AST-120, hyperbaric oxygen therapy, tacrolimus enemas, and granulocyte and monocyte apheresis suggested some efficacy.</p><p><strong>Conclusion: </strong>The available data are weak but suggest that therapeutic options for chronic antibiotic-refractory pouchitis are similar to the treatment strategies for inflammatory bowel diseases. However, randomized controlled trials are warranted to further identify the best treatment options in this patient population.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"277-290"},"PeriodicalIF":2.4,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/5c/ceg-14-277.PMC8213947.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39099085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease? 非酒精性胰腺脂肪变性总是与非酒精性脂肪肝相关吗?
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-11 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S317340
Celal Ulasoglu, Zeynep Nilufer Tekin, Kubra Akan, Arda Yavuz
Purpose To identify the correlation of nonalcoholic pancreatic steatosis (NAPS) with nonalcoholic fatty liver disease (NAFLD) in an outpatient group. Based on its metabolic and imaging properties, NAPS has been increasingly recognized in recent years; however, its interaction with NAFLD is still not clear. Patients and Methods In this cross-sectional observational study, 345 consecutive patients without any chronic illness who were referred to the senior radiologist for abdominal ultrasound (US) were included. The US report showed hepatic and pancreatic echogenicity. The patients’ demographic, anthropometric, and laboratory data were collected from medical records. Results Overall, NAPS and NAFLD were seen in 227 (65.8%) and 219 (63.5%) patients, respectively. Normal echogenicity was noted in 74 (21.4%) patients. Forty-four patients (12.8%) had steatotic liver without NAPS, 52 (15.1%) had steatotic pancreas without NAFLD, and 175 (50.7%) had steatosis in both organs. The discordance in steatosis grading between NAPS and NAFLD was 55.1%. Insulin resistance was present in 8.7, 26.7, 19, and 61.3% of patients with no steatosis, only NAFLD, only NAPS, and steatosis in both organs, respectively. Evident NAFLD and NAPS having grade 2 and 3 steatosis were present in 15.3% and 29.0% of the study group, respectively. Cholecystolithiasis was present in 6.8, 13.6, and 28.8% of patients with normal echogenic pancreas, only NAFLD, and only NAPS, respectively (p=0.01). Conclusion Based on the ultrasonographic, clinical, demographic, and anthropometric features of the included patients, we found that NAPS did not fully accompany nonalcoholic fatty liver. Despite severe pancreatic steatosis, more than a quarter of cases had normal liver echogenicity. Insulin resistance frequency was insignificantly higher in NAFLD than NAPS (p=0.694). The significantly higher frequency of cholecystolithiasis in NAPS needs further large-scale studies. The inconsistency of steatosis degree in NAPS and NAFLD in >50% cases may reflect differences in the pathophysiology of these two clinical entities.
目的:在门诊组中确定非酒精性胰腺脂肪变性(NAPS)与非酒精性脂肪性肝病(NAFLD)的相关性。近年来,基于其代谢和成像特性,nap得到越来越多的认可;然而,其与NAFLD的相互作用尚不清楚。患者和方法:在这项横断面观察性研究中,纳入了345名连续无任何慢性疾病的患者,这些患者被转介给高级放射科医生进行腹部超声检查(US)。美国报告显示肝脏和胰腺回声。从医疗记录中收集患者的人口统计学、人体测量学和实验室数据。结果:总体而言,nap和NAFLD分别出现227例(65.8%)和219例(63.5%)。74例(21.4%)患者回声正常。44例(12.8%)患者为无NAFLD的脂肪变性肝,52例(15.1%)患者为无NAFLD的脂肪变性胰腺,175例(50.7%)患者为双器官脂肪变性。nap与NAFLD在脂肪变性分级上的差异为55.1%。无脂肪变性、只有NAFLD、只有nap和双器官脂肪变性的患者分别有8.7、26.7%、19%和61.3%存在胰岛素抵抗。明显的NAFLD和2级和3级脂肪变性的nap分别出现在15.3%和29.0%的研究组中。胰腺回声正常的患者中有6.8%、13.6%和28.8%存在胆囊结石,只有NAFLD和只有nap (p=0.01)。结论:基于所纳入患者的超声、临床、人口学和人体测量学特征,我们发现nap并不完全伴有非酒精性脂肪肝。尽管严重的胰腺脂肪变性,超过四分之一的病例肝脏回声正常。NAFLD患者胰岛素抵抗频率显著高于nap患者(p=0.694)。nap患者胆囊结石发生率的显著增高需要进一步的大规模研究。>50%的nap与NAFLD脂肪变性程度不一致可能反映了这两种临床实体在病理生理上的差异。
{"title":"Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?","authors":"Celal Ulasoglu,&nbsp;Zeynep Nilufer Tekin,&nbsp;Kubra Akan,&nbsp;Arda Yavuz","doi":"10.2147/CEG.S317340","DOIUrl":"https://doi.org/10.2147/CEG.S317340","url":null,"abstract":"Purpose To identify the correlation of nonalcoholic pancreatic steatosis (NAPS) with nonalcoholic fatty liver disease (NAFLD) in an outpatient group. Based on its metabolic and imaging properties, NAPS has been increasingly recognized in recent years; however, its interaction with NAFLD is still not clear. Patients and Methods In this cross-sectional observational study, 345 consecutive patients without any chronic illness who were referred to the senior radiologist for abdominal ultrasound (US) were included. The US report showed hepatic and pancreatic echogenicity. The patients’ demographic, anthropometric, and laboratory data were collected from medical records. Results Overall, NAPS and NAFLD were seen in 227 (65.8%) and 219 (63.5%) patients, respectively. Normal echogenicity was noted in 74 (21.4%) patients. Forty-four patients (12.8%) had steatotic liver without NAPS, 52 (15.1%) had steatotic pancreas without NAFLD, and 175 (50.7%) had steatosis in both organs. The discordance in steatosis grading between NAPS and NAFLD was 55.1%. Insulin resistance was present in 8.7, 26.7, 19, and 61.3% of patients with no steatosis, only NAFLD, only NAPS, and steatosis in both organs, respectively. Evident NAFLD and NAPS having grade 2 and 3 steatosis were present in 15.3% and 29.0% of the study group, respectively. Cholecystolithiasis was present in 6.8, 13.6, and 28.8% of patients with normal echogenic pancreas, only NAFLD, and only NAPS, respectively (p=0.01). Conclusion Based on the ultrasonographic, clinical, demographic, and anthropometric features of the included patients, we found that NAPS did not fully accompany nonalcoholic fatty liver. Despite severe pancreatic steatosis, more than a quarter of cases had normal liver echogenicity. Insulin resistance frequency was insignificantly higher in NAFLD than NAPS (p=0.694). The significantly higher frequency of cholecystolithiasis in NAPS needs further large-scale studies. The inconsistency of steatosis degree in NAPS and NAFLD in >50% cases may reflect differences in the pathophysiology of these two clinical entities.","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"269-275"},"PeriodicalIF":2.4,"publicationDate":"2021-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/74/ceg-14-269.PMC8205613.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39248998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis. 酒精性肝炎患者血液中非经典单核细胞减少与疾病严重程度相关
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-09 eCollection Date: 2021-01-01 DOI: 10.2147/CEG.S299775
Elisabeth Busk Rasmussen, Lotte Lindgreen Eriksen, Stinne Ravn Greisen, Anne Louise Hansen, Mikkel Carstensen, Thomas Damgaard Sandahl, Sidsel Støy, Tue Wenzel Kragstrup

Objective: Alcoholic hepatitis (AH) holds a high mortality, and vast macrophage infiltration of the liver is involved in the progressive liver injury. No efficient medical treatment exists, and macrophages may be a future treatment target. Here, we examine associations between non-classical monocyte subsets and cell surface markers of migration with disease activity in patients with severe AH.

Methods: We analyzed samples from two cohorts of patients with AH. Cohort 1 included 15 AH patients, followed for 30 days, and 8 healthy controls (HCs). Cohort 2 included 23 AH patients, followed for 90 days, and 9 HCs. Peripheral blood mononuclear cells (PBMCs) from both cohorts were analyzed by flow cytometry. Liver biopsies from cohort 2 were analyzed by RNA sequencing.

Results: Circulating non-classical monocytes in all but absent in patients with AH compared to HC in both cohorts (both p<0.0001). The frequency of non-classical monocytes was significantly associated with Maddrey's discriminant function (mDF) (r=-0.79, p=0.0008, cohort 1), Child-Pugh score (CP) (r=-0.56, p=0.03, cohort 1), Model for End-Stage Liver Disease (MELD) (r=-0.54, p=0.02, cohort 2) and C-reactive protein (CRP) (r=-0.51, p=0.027, cohort 2). The surface expression of CD11b was increased on non-classical monocytes in patients with AH compared to HC (p<0.0001) (cohort 1). The mRNA expression of CD11b was increased in liver biopsies in patients with AH compared to HC (cohort 2) (p<0.0001).

Conclusion: In this study, we describe an almost complete depletion of circulating non-classical monocytes in the blood in two independent cohorts of patients with AH, which may be associated with a possible harmful recruitment of these cells to the liver. These results contribute to a better understanding of the disease, which hopefully can lead to therapies that target the acute inflammatory response leading to severe AH.

目的:酒精性肝炎(AH)死亡率高,肝脏巨噬细胞大量浸润参与了进行性肝损伤。目前还没有有效的治疗方法,巨噬细胞可能是未来的治疗靶点。在这里,我们研究了非经典单核细胞亚群和细胞表面迁移标志物与严重AH患者疾病活动性之间的关系。方法:我们分析了两组AH患者的样本。队列1包括15例AH患者,随访30天,8例健康对照(hc)。队列2包括23例AH患者,随访90天,9例hcc患者。用流式细胞术分析两组患者外周血单个核细胞(PBMCs)。队列2的肝脏活检通过RNA测序进行分析。结果:与HC相比,两组AH患者均存在循环非经典单核细胞(pr=-0.79, p=0.0008,队列1),Child-Pugh评分(CP) (r=-0.56, p=0.03,队列1),终末期肝病模型(MELD) (r=-0.54, p=0.02,队列2)和c反应蛋白(CRP) (r=-0.51, p=0.027,队列2)。AH患者非经典单核细胞表面CD11b表达高于HC (p)。在这项研究中,我们描述了在两个独立的AH患者队列中血液中循环非经典单核细胞几乎完全耗尽,这可能与这些细胞向肝脏的可能有害募集有关。这些结果有助于更好地了解这种疾病,有望导致针对导致严重AH的急性炎症反应的治疗。
{"title":"Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis.","authors":"Elisabeth Busk Rasmussen,&nbsp;Lotte Lindgreen Eriksen,&nbsp;Stinne Ravn Greisen,&nbsp;Anne Louise Hansen,&nbsp;Mikkel Carstensen,&nbsp;Thomas Damgaard Sandahl,&nbsp;Sidsel Støy,&nbsp;Tue Wenzel Kragstrup","doi":"10.2147/CEG.S299775","DOIUrl":"https://doi.org/10.2147/CEG.S299775","url":null,"abstract":"<p><strong>Objective: </strong>Alcoholic hepatitis (AH) holds a high mortality, and vast macrophage infiltration of the liver is involved in the progressive liver injury. No efficient medical treatment exists, and macrophages may be a future treatment target. Here, we examine associations between non-classical monocyte subsets and cell surface markers of migration with disease activity in patients with severe AH.</p><p><strong>Methods: </strong>We analyzed samples from two cohorts of patients with AH. Cohort 1 included 15 AH patients, followed for 30 days, and 8 healthy controls (HCs). Cohort 2 included 23 AH patients, followed for 90 days, and 9 HCs. Peripheral blood mononuclear cells (PBMCs) from both cohorts were analyzed by flow cytometry. Liver biopsies from cohort 2 were analyzed by RNA sequencing.</p><p><strong>Results: </strong>Circulating non-classical monocytes in all but absent in patients with AH compared to HC in both cohorts (both p<0.0001). The frequency of non-classical monocytes was significantly associated with Maddrey's discriminant function (mDF) (<i>r</i>=-0.79, p=0.0008, cohort 1), Child-Pugh score (CP) (<i>r</i>=-0.56, p=0.03, cohort 1), Model for End-Stage Liver Disease (MELD) (<i>r</i>=-0.54, p=0.02, cohort 2) and C-reactive protein (CRP) (<i>r</i>=-0.51, p=0.027, cohort 2). The surface expression of CD11b was increased on non-classical monocytes in patients with AH compared to HC (p<0.0001) (cohort 1). The mRNA expression of CD11b was increased in liver biopsies in patients with AH compared to HC (cohort 2) (p<0.0001).</p><p><strong>Conclusion: </strong>In this study, we describe an almost complete depletion of circulating non-classical monocytes in the blood in two independent cohorts of patients with AH, which may be associated with a possible harmful recruitment of these cells to the liver. These results contribute to a better understanding of the disease, which hopefully can lead to therapies that target the acute inflammatory response leading to severe AH.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"259-267"},"PeriodicalIF":2.4,"publicationDate":"2021-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/33/ceg-14-259.PMC8200175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39238391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Systemic Disease Associations with Disorders of Gut-Brain Interaction and Gastrointestinal Transit: A Review. 系统性疾病与肠-脑相互作用和胃肠道转运障碍的关系:综述。
IF 2.4 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2021-06-08 DOI: 10.2147/CEG.S283685
Rohitha Moudgal, Andrew W Schultz, Eric D Shah

Functional gastrointestinal disorders (FGID) are now classified within the Rome IV framework as disorders of gut-brain interaction (DGBI). Disorders of gastrointestinal transit (as defined by abnormalities on contemporary gastrointestinal motility testing) frequently are associated with symptoms that are also characteristic of DGBIs. In this narrative review, we outline a non-inclusive set of systemic diseases or risk factors that have been classically associated with DGBIs and disorders of gastrointestinal transit; these include diabetes mellitus, paraneoplastic syndromes, surgery, Parkinson's disease, systemic sclerosis, endocrinopathies, polypharmacy, and post-infectious syndromes.

功能性胃肠道疾病(FGID)现在在罗马IV框架内被归类为肠脑相互作用疾病(DGBI)。胃肠道转运障碍(定义为当代胃肠动力测试异常)通常与DGBI的症状相关。在这篇叙述性综述中,我们概述了一组非包容性的系统性疾病或风险因素,这些疾病或风险因子通常与DGBI和胃肠道转运障碍有关;这些疾病包括糖尿病、副肿瘤综合征、外科手术、帕金森病、系统性硬化症、内分泌疾病、多药治疗和感染后综合征。
{"title":"Systemic Disease Associations with Disorders of Gut-Brain Interaction and Gastrointestinal Transit: A Review.","authors":"Rohitha Moudgal,&nbsp;Andrew W Schultz,&nbsp;Eric D Shah","doi":"10.2147/CEG.S283685","DOIUrl":"10.2147/CEG.S283685","url":null,"abstract":"<p><p>Functional gastrointestinal disorders (FGID) are now classified within the Rome IV framework as disorders of gut-brain interaction (DGBI). Disorders of gastrointestinal transit (as defined by abnormalities on contemporary gastrointestinal motility testing) frequently are associated with symptoms that are also characteristic of DGBIs. In this narrative review, we outline a non-inclusive set of systemic diseases or risk factors that have been classically associated with DGBIs and disorders of gastrointestinal transit; these include diabetes mellitus, paraneoplastic syndromes, surgery, Parkinson's disease, systemic sclerosis, endocrinopathies, polypharmacy, and post-infectious syndromes.</p>","PeriodicalId":10208,"journal":{"name":"Clinical and Experimental Gastroenterology","volume":"14 ","pages":"249-257"},"PeriodicalIF":2.4,"publicationDate":"2021-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/d8/ceg-14-249.PMC8197439.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39238390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Clinical and Experimental Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1